A Brugarolas, H Takita, G E Moore. Show Affiliations »
Abstract
Entities: Disease
Mesh： See more » AnimalsAzo CompoundsBiphenyl CompoundsConcanavalin A/therapeutic useCyanosis/prevention & controlEdema/prevention & controlForelimbHumansImmunotherapyLectins/therapeutic useMiceMice, Inbred StrainsMultiple Myeloma/complicationsMultiple Myeloma/immunologyMultiple Myeloma/pathologyMultiple Myeloma/therapyNecrosis/prevention & controlParesis/prevention & controlSkin Diseases/prevention & controlTime FactorsVaccinesgamma-Globulins/therapeutic use
Substances： See more » Azo CompoundsBiphenyl CompoundsLectinsVaccinesgamma-GlobulinsConcanavalin A
Year: 1972 PMID： 4113482 DOI： 10.1002/jso.2930040207
Source DB: PubMed Journal: J Surg Oncol ISSN： 0022-4790 Impact factor: 3.454